Has Joseph David, MD received payments from drug or device companies?

Yes. Drug and device makers reported $489 in general payments to Joseph David, MD across 29 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joseph David, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joseph David, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joseph David, MD

Psychiatry · Charlottesville, VANPI 1033117502

Payments from drug & device makers

$489in general payments, 2019–2025

Across 29 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sunovion Pharmaceuticals Inc.$284
Biodelivery Sciences International, Inc.$56
Lilly USA, LLC$36
Takeda Pharmaceuticals U.S.A., Inc.$34
AbbVie$33
Shire North American Group Inc$28
plus $16 from 1 others

What the payments were for

Food & beverage$489100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sunovion Pharmaceuticals Inc.	17	$284
Biodelivery Sciences International, Inc.	3	$56
Lilly USA, LLC	2	$36
Takeda Pharmaceuticals U.S.A., Inc.	2	$34
AbbVie	2	$33
Shire North American Group Inc	2	$28
Novo Nordisk	1	$16

How this compares

$489 in reported general payments places this provider in the 60th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia →

Medicare billing

Part B allowed, 2024

$53,069

Medicare patients

Services billed

580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clozapine	14	$2,052
Bupropion XlBupropion Hcl	45	$1,224
Quetiapine Fumarate	25	$961
Fluoxetine Hcl	23	$575
Escitalopram Oxalate	16	$528
Lithium Carbonate	17	$339
Lorazepam	28	$327
Buspirone Hcl	13	$290
Clonazepam	13	$215
Duloxetine Hcl	13	$184
Diazepam	29	$144
Alprazolam	16	$32

Paid to pharmacies, not to this prescriber.

Other psychiatry in Charlottesville

Anita ClaytonCharlottesville$356K
Randolph CanterburyCharlottesville$90K
Anne StewartCharlottesville$67K
Jennifer PayneCharlottesville$43K
Niku SinghFalls Church$2.5M
David ScheidererRoanoke$2.4M
Kent McDanielGlen Allen$2.1M
Jasdeep MiglaniManassas$958K
Frederick MoellerRichmond$678K
David SpiegelNorfolk$565K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →